Maximus, Inc. operates as a provider of government services worldwide. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; subsidized telephone services; and person-centered independent assessment services. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The Outside the U.S. segment offers BPS and technology solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and technologies for modernization. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.

Maximus, Inc.

In a report released yesterday, Atsushi Ikeda from Goldman Sachs maintained a Buy rating on Mitsui Kinzoku Co, with a price target of Yen43,200.00....

Goldman Sachs Reaffirms Their Buy Rating on Mitsui Kinzoku Co (XZJCF)

In a report released today, Phillip Chippindale from Ord Minnett maintained a Buy rating on Mcmillan Shakespeare Limited, with a price target of A$...

Ord Minnett Sticks to Their Buy Rating for Mcmillan Shakespeare Limited (NMN)

Mcmillan Shakespeare Limited ( ($AU:MMS) ) has provided an update. McMillan Shakespeare Limited reported a record FY26 performance, with revenue ri...

McMillan Shakespeare posts record FY26 profit on EV-led novated growth

An update from Mcmillan Shakespeare Limited ( ($AU:MMS) ) is now available. McMillan Shakespeare Limited has declared a fully franked interim divid...

McMillan Shakespeare Declares AUD 0.70 Interim Dividend for Half-Year 2026

An announcement from Mcmillan Shakespeare Limited ( ($AU:MMS) ) is now available. McMillan Shakespeare Limited has lodged its 2026 Appendix 4G and ...

McMillan Shakespeare Files 2026 Governance Statement with ASX

Madmind Studio SA ( ($PL:MMS) ) has shared an update. Madmind Studio S.A. has convened its Ordinary General Meeting for 7 September 2026 in Warsaw,...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MMS	$57.88	-0.94%	95.25K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MMS	$57.88	-0.9%	95.25K
3
4
5
6

MMS

Get Maximus, Inc. Data in Excel

Get Maximus, Inc. Data in Excel